BioSpace News Archive

Calliditas Therapeutics AB announced that CEO Renée Aguiar-Lucander has net purchased 50,000 shares through Calliditas’ warrant program 2019/2022.

QureBio Ltd. today announced that Phase Ⅰ Clinical Data of its Q-1802 program will be presented at ASCO Gastrointestinal Cancers Symposium (ASCO-GI) hold at the San Francisco and online on January 19–21, 2023.

Terns Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 10,350,000 shares of its common stock at a public offering price of $7.25 per share, before underwriting discounts and commissions.

Oragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, announced that it received a Notice on December 19, 2022 from the NYSE American LLC stating that the Company is not in compliance with the continued listing standards as set forth in Section 1003 of the NYSE American Company Guide.

PENTAX Medical America has launched a new fast endoscope drying solution - the PlasmaTYPHOONdry.

Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in G protein-coupled receptor (GPCR) focused structure-based drug design (SBDD) and development, has been notified by Pfizer that the first subject in a Phase 2 clinical trial has been dosed with Pfizer’s candidate PF-07081532.